| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Starry Group Holdings, Inc. (NYSE:STRY) (the “Company” or “Starry”), a licensed fixed wireless technology developer and internet service provider, today announced that on November 8, 2022, it had received a deficiency letter from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with applicable price criteria in the NYSE’s continued listing standards because, as of November 7, 2022, the average closing price of the Starry’s Class A Common Stock was less than $1.00 per share over a consecutive 30 trading-day period.
Pursuant to the NYSE’s rules, Starry has a six-month period following receipt of the deficiency letter to bring its share price and average share price back above $1.00. The NYSE rules require Starry to notify the NYSE within 10 business days of receipt of the NYSE notice of its intent to cure this deficiency. Starry plans to notify the NYSE of its intent to cure within the applicable time period.
Starry’s Class A Common Stock will continue to be listed and trade on the NYSE during this period, subject to Starry’s compliance with other NYSE continued listing standards. Starry’s receipt of the deficiency letter does not affect the Company’s business, operations or reporting requirements with the Securities and Exchange Commission.
Posted In: STRY
